Showing 8 posts of 8 posts found.


Fat-fighting pharma business files for bankruptcy

March 15, 2018
Sales and Marketing Contrave, biotech, drugs, orexigen, pharma, pharmaceutical

Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it …

FDA issued the fewest warnings over pharma advertising this year since 1997

December 11, 2017
Sales and Marketing Amherst, FDA, advertising, cipher, orexigen, pharma

Throughout 2017, it has emerged that the FDA has issued a record low number of warning letters to pharmaceutical firms …


Weight loss pill treatment rejected by NICE

May 8, 2017
Medical Communications, Sales and Marketing NICE, orexigen

NICE has announced, in an Appraisal Consultation Document, that it is not able to recommend Orexigen’s Mysimba as a weight …


Orexigen and Takeda reboot Contrave collaboration

August 12, 2015
Research and Development Contrave, FDA, Takeda, orexigen, weight loss drugs

Orexigen has agreed to foot the $200 million bill for a new trial to prove its claims that Contrave, the …


Takeda hits major snags with Contrave and Alisertib

May 14, 2015
Sales and Marketing Contrave, Takeda, alisertib, obesity, orexigen

Takeda is threatening to end its partnership with Orexigen to market the obesity drug Contrave, as allegations around its heart …

Chiesi gets first-ever European stem cell nod

December 19, 2014
Sales and Marketing Chiese, Chiesi, EMA, Holoclar, LSCD, MHRA, Stem cells, orexigen

Chiesi has received the first approval for an advanced therapy medicinal product containing stem cells for use in Europe. The …

Contrave image

Sanofi to produce weight-loss drug for Orexigen

November 11, 2013
Manufacturing and Production, Sales and Marketing Contrave, FDA, Sanofi, orexigen

Sanofi has agreed a deal to manufacture Orexigen Therapeutics’ weight-loss candidate Contrave outside North America. Under the commercial supply agreement, …


Orexigen’s chief executive elected to PhRMA Board

April 23, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PhRMA, orexigen

Biopharma firm Orexigen has announced that its president and chief executive Michael Narachi has been elected to the Board of …

Latest content